In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...

More information: Victoria R. Votaw et al, Examining cocaine use reductions and long-term outcomes in two clinical trials of continuing care for cocaine dependence, Journal of Substance Use and ...

which also included very few side effects. Calixcoca has protected rat fetuses from cocaine, a result that, if replicated in humans, could help in the treatment of pregnant women with addiction ...

the group conducted a Phase II clinical trial with 68 people with a diagnosed cocaine use disorder. Mavoglurant was first developed by a team at Novartis as a treatment for fragile X syndrome ...

After years of rising, the percentage of students in grades 9 through 12 who had tried cannabis, cocaine ... Three treatment programs, in particular, have shown the best outcomes for adolescents.

We postulate that, because dopamine and serotonin both mediate schizophrenia symptoms and underlie the reinforcing effects ... treatment for patients with comorbid schizophrenia and cocaine ...

Clinical trials are currently underway to determine the effectiveness of acupuncture in the treatment of drug addiction ... role in reducing reinforcing effects of abused drugs.